Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Outcomes of CAR T-Cell Therapy Versus Autologous HSCT in Patients with Large B-Cell Lymphoma in Complete Remission

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Dr. Remy DULERY

Résultats de la thérapie par cellules CAR-T versus autogreffe de cellules souches hématopoïétiques chez les patients atteints de lymphome B diffus à grandes cellules en rémission complète

Études rétrospectives

Lymphome non hodgkinien (LNH)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Dr. Remy DULERY

Allogeneic Stem Cell Transplant in Primary CNS Lymphoma

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Greffe allogénique de cellules souches hématopoïétiques dans le lymphome primitif du système nerveux central

Études rétrospectives

Lymphome non hodgkinien (LNH)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Axicabtagene ciloleucel and lisocabtagene maraleucel as second-line treatment for patients with relapsed or refractory DLBCL - a real-world analysis of the lymphoma working party of the EBMT

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Dr. Anna Ossami SAIDY

Real World Experience of CAR-T in follicular lymphoma: a Lymphoma Working Party-EBMT study

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Dr. Leyre BENTO & Dr. Silvia MONTOTO

Expérience en vie réelle des thérapies CAR-T dans le lymphome folliculaire : étude du Lymphoma Working Party de l’EBMT

Études rétrospectives

Lymphome non hodgkinien (LNH)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Dr. Leyre BENTO & Dr. Silvia MONTOTO

Non-interventional registry-based analysis in the use of Brentuximab Vedotin and/or Checkpoint inhibitors as bridge to autologous stem cell transplantation in Hodgkin lymphoma.

Non-interventional Prospective Studies

Hodgkin’s Disease (HD)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Dr. Ali BAZARBACHI & Dr. Anna SUREDA

Autologous, Allogeneic Stem-Cell Transplantation and CART Cell therapy for Transformed Waldenström Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL) to High Grade NHL (HGNHL)

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Dr. Charalampia KYRIAKOU & Dr. Nour MOUKALLED

Stem cell transplantation for ALK-pos. and ALK-neg. anaplastic large cell lymphoma: a retrospective analysis of the EBMT-Lymphoma Working Party

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Dr. Evgenii SHUMILOV & Dr. Norbert SCHMITZ

Exploring the Role of AlloHCT in the Modern Era of R/R Mantle Cell Lymphoma

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Dr. Nora LIEBERS & Dr. Sascha DIETRICH

Outcomes after CAR T-cell therapy in Primary Mediastinal B-Cell Lymphoma: a real-world study of the Lymphoma Working Party of the EBMT

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Dr. Remy DULERY